Vexev's medical robotics team growing in Sydney
Vexev's ROS 2-based medical robotics team is hiring in Sydney...
Vexev, an Australian medtech startup, is scaling its Sydney-based robotics team to accelerate development of its medical imaging robots built on ROS 2 (Robot Operating System 2). The company has gained significant traction since its CEO Deanna Hood presented at ROSCon, with engineers eager to contribute to a project that could transform global cardiovascular healthcare. Vexev's robots are designed for FDA clearance and have already demonstrated impact in dialysis clinics, with users reportedly moved to tears by the potential life-saving capabilities.
The company is now hiring for multiple technical roles, including Senior Software Engineers specializing in Applied AI & Robotics, DevOps/Observability Engineers, and Technical Software Product Managers. While ROS 2 expertise is valued, the team emphasizes that not all roles are robotics-centric, welcoming diverse technical backgrounds. The positions are based in Sydney, Australia, with some roles offering part-time options starting August 1, 2026. Interested candidates can explore opportunities through Vexev's website or express interest via their open call process.
- Vexev is hiring robotics engineers in Sydney to develop FDA-cleared medical imaging robots using ROS 2
- The medical robots target end-stage kidney disease and broader cardiovascular health applications
- Multiple technical roles available including Senior Software Engineer, DevOps Engineers, and Product Managers (some part-time options)
Why It Matters
Advancing medical robotics that could save lives worldwide while using open-source ROS 2 infrastructure